FDA issued a Warning Letter to Hameln Pharmaceuticals Gmbh on 12/17/2012 for a previous inspection.
483 Siegfried Hameln Gmbh Apr 2018

483 Siegfried Hameln Gmbh Apr 2018

Margaret Annes FDA$119.00 - Available Now

FDA investigators audited the Siegfried Hameln Gmbh - Hameln, Germany facility and issued inspectional observations (via FDA 483) on 24 Apr 2018.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 24 Apr 2018
  • Location: Hameln, Germany
  • FEI: 3002807877
Add To Cart